We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Coronavirus Attacks Blood Vessels Across Body to Cause Multiple Organ Failure, Finds Study

By HospiMedica International staff writers
Posted on 27 Apr 2020
Print article
Image: Coronavirus Attacks Blood Vessels across Body to Cause Multiple Organ Failure, Finds Study (Photo courtesy of University Hospital Zurich)
Image: Coronavirus Attacks Blood Vessels across Body to Cause Multiple Organ Failure, Finds Study (Photo courtesy of University Hospital Zurich)
A study conducted by University Hospital Zurich (Zurich, Switzerland) has found that the coronavirus attacks the lining of blood vessels across the body, ultimately resulting in multiple organ failure.

The researchers found that the deadly virus caused more than just pneumonia and enters the endothelium (layer of cells), which acts as a defense line of the blood vessels, causing circulation problems in the smallest of blood vessels. The coronavirus then reduces the blood flow to different parts of the body and eventually stops blood circulation. This also explains why smokers and those with pre-existing conditions, such as hypertension, or high blood pressure, diabetes, obesity and established cardiovascular disease, having a weakened endothelial function, or unhealthy blood vessels, were more vulnerable to the novel coronavirus.

Based on an analysis of three cases, the study found viral elements within endothelial cells, which line the inside of blood vessels, and inflammatory cells in COVID-19 patients. Autopsies performed on other COVID-19 patients also found their blood vessel linings to be “full of virus” and impaired functioning of vessels in all their organs. Based on these findings, the researchers have suggested therapies to stabilize the endothelium in addition to vaccination that reduces virus replication, and believe that strengthening vascular health could hold the key to treating COVID-19 patients.

“This virus does not only attack the lungs, it attacks the vessels everywhere,” said Frank Ruschitzka, an author of the paper from University Hospital Zurich. “From what we do see clinically, patients have problems in all organs – in the heart, kidney, intestine, everywhere. All patients who are at risk and the elderly should be treated very well for the underlying cardiovascular conditions. The better they are treated, the more likely they are to survive the COVID-19 infection.”

Related Links:
University Hospital Zurich

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Vital Signs Monitor
iM3s
New
Electrocardiograph
BeneHeart R700/R900

Print article

Channels

Critical Care

view channel
Image: The Atmo Gas Capsule measures gases as it travels through the GI tract and transmits the data wirelessly (Photo courtesy of Atmo Biosciences)

Ingestible Smart Capsule for Chemical Sensing in the Gut Moves Closer to Market

Intestinal gases are associated with several health conditions, including colon cancer, irritable bowel syndrome, and inflammatory bowel disease, and they have the potential to serve as crucial biomarkers... Read more

Surgical Techniques

view channel
Image: Intravascular imaging can improve outcomes for complex stenting procedures in patients with high-risk calcified coronary artery disease (Photo courtesy of Shutterstock)

Intravascular Imaging for Guiding Stent Implantation Ensures Safer Stenting Procedures

Patients diagnosed with coronary artery disease, which is caused by plaque accumulation within the arteries leading to chest pain, shortness of breath, and potential heart attacks, frequently undergo percutaneous... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more